2014 Europe Annual Conference

2014 Europe Annual Conference

2014 Europe Annual Conference

 

Share:          

Executive Forum

The Executive Forum will offer pharmaceutical executives, senior experts and future decision makers a platform to interactively examine the current challenges in technical operations and dominant factors to achieving successful pharmaceutical manufacturing, namely — safety, efficiency and compliance during development, transfer, production and distribution.

In particular, the executive session will focus on ensuring supply chain integrity, managing lean and compliant operations and avoiding drug shortages.

Dr. Martin Bergen, Managing Director of SecurPharm will focus on the implementation of the Falsified Medicines Directive, Delegated Acts and Mass Serialisation. How companies can prepare systems and processes for drug delivery effectively and in time.

Dr.  Paul Rutten, Principal at McKinsey & Co, the Netherlands will talk about the perceived trade-off between fulfilling GMP compliance and lean production based on benchmark studies undertaken by McKinsey and Co. An interactive session will provide opportunity for dialogue and sharing experiences.

Drug Shortages - a Multi-layered Challenge Across the Whole Supply Chain.
Input and updates from industry experts and agencies will reflect on the current drug shortages initiatives. Discussions will incorporate FDA guidance, the EMA reflection paper, the ISPE industry survey and the latest updates on the industry-regulator dialogue on preventative concepts and best practice examples to avoid drug shortages. Dialogue will also focus on the robustness of the installed pharmaceutical quality systems, the relevance of quality culture and behaviours within corporations. Join the discussion and contribute to the action plan being developed in Europe to mitigate shortages.

Highlights of the Executive Forum:

  • Implementing the Falsified Medicines Directive, especially with respect to the status of the Delegated Acts of the European Commission and to Mass Serialization.
  • McKinsey-led session on the prevalent concerns of technical operations, as outlined in recent benchmark McKinsey studies.
  • The developing action plan in Europe to mitigate shortages resulting from manufacturing and quality issues.

Who should attend?

The Executive Forum is meant for Executives, Senior Experts and Future Decision Makers from all Functions in Pharmaceutical Operations, Development, Regulatory Affairs, Quality, Production, Engineering Management and Supply Chain Management.

Programme

13.00 – 13.15

Opening and Welcome 

Official Welcome Address by Dr. Karl-Heinz Menges, Pharmacist, Regierungspraesidium Darmstadt / Regional Council Darmstadt
Dr. Thomas Zimmer, Vice President, European Operations, ISPE

13.15 – 14.00

SecurPharm – The German Solution against Falsified Medicines

Dr. Martin Bergen, Managing Director, SecurPharm Germany

14.00 – 14.30 Networking Break
14.30 – 16.10

The Big Challenge for Pharmaceutical Operations in Europe: Managing Compliance and Quality under New Requirements and the Perceived Trade-Off to Lean, Agile and Flexible Production
 

Dr. Paul Rutten, Principal at McKinsey & Co, the Netherlands

16.10 – 16.15

Drug Shortages: Update and Request for Input on Initiatives Aimed at Preventing Shortages

Introduction to speakers, topics and objectives: Dr. John Berridge, Strategic Advisor, ISPE

16.15 – 16.35

EMA initiatives on Drug Shortages

Dr. Brendan Cuddy, Scientific Administrator, European Medicines Agency (EMA)

16.35 – 17.00

The Inter-Association Shortages Prevention Project

Dr. John Berridge, Strategic Advisor, ISPE, and Emma Ramnarine, Senior Director, Head Global Biologics QC Network, Genentech Roche/PDA Task Force Leader for TR54 QRM and TR54 Annex 4 Drug Shortages, PDA

17.00 – 17.25

The Inter-Association Shortages Communication Project

Dr. Birgitte Holst, Director, Novo Nordisk/ Member of Technical Development and Operations Committee, EFPIA, and Julie Marechal-Jamil, Senior Manager Quality & Regulatory Affairs at European Generic Medicines Association (EGA)

17.25 – 17.50

Panel Discussion

Moderator: Dr. John Berridge, Strategic Advisor, ISPE

Panellists: Speaker line-up from the Drug Shortages Topic, including Dr. Jacques Morenas, Deputy Director, Inspectorate and Companies Department, ANSM, and Mark Birse, Group Manager GMDP, MHRA

17.50 - 18.10

Closing Remarks

Dr. Thomas Zimmer, Vice President, European Operations, ISPE

19.00 Dinner

Speakers

Executive Forum Chair: 
 PhotoThomas Zimmer,
Vice President, European Operations, ISPE

Speakers: 
 PhotoDr. Martin Bergen,
Managing Director, securPharm, Germany

 PhotoJohn Berridge
Strategic Advisor, ISPE, UK

 PhotoDr. Brendan Cuddy
Scientific Administrator, EMA, UK

 PhotoDr. Birgitte Holst,
Director, Novo Nordisk/EFPIA, Denmark

 PhotoJulie Marechal-Jamil,
Senior Manager Quality & Regulatory Affairs at European Generic Medicines Association (EGA), Belgium

 PhotoDr. Karl-Heinz Menges,
Pharmacist, Regierungspraesidium Darmstadt / Regional Council Darmstadt, Germany

 PhotoEmma Ramnarine,
Head, Global Biologics QC Network Genentech/Roche (PDA), US

 PhotoDr. Paul Rutten,
Principal, McKinsey, the Netherlands

 

Thank you to our Top Tier Sponsors

  • Pinnacle Sponsor
  • Pinnacle Sponsor
  • Pinnacle Sponsor
  • Silver Sponsor
  • Bronze Sponsor
  • Media Partners

Follow ISPE

ISPE Twitter Page ISPE Facebook Page ISPE LinkedIn Page